GRANULES PHARMACEUTICALS H-1B Visa Sponsorship & Salary Data

The median H-1B salary at GRANULES PHARMACEUTICALS is $78,000, based on 132 certified filings from FY 2020 to FY 2026. This is 35% lower than the national H-1B median salary of $120,000. Compensation at GRANULES PHARMACEUTICALS reflects their market positioning, with entry-level roles starting around $65,000 and senior positions reaching $144,997 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at GRANULES PHARMACEUTICALS range from $60,000 at the 10th percentile to $144,997 at the 90th percentile, showing a $84,997 spread across experience levels and roles. The 25th percentile is $65,000 and the 75th percentile is $120,000.

Yes, GRANULES PHARMACEUTICALS actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 135 H-1B labor condition applications from FY 2020 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 132 certified applications and a 2.2% denial rate, GRANULES PHARMACEUTICALS maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), GRANULES PHARMACEUTICALS filed 3 H-1B applications, with 3 certified and 0 denied. Over 7 years of data, GRANULES PHARMACEUTICALS has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

GRANULES PHARMACEUTICALS's LCA (Labor Condition Application) denial rate is 2.2%, with 3 out of 135 applications denied across all years. This translates to a 97.8% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating GRANULES PHARMACEUTICALS as a potential H-1B sponsor.

This denial rate is higher than average. Applicants should ensure all documentation is thoroughly prepared and work closely with GRANULES PHARMACEUTICALS's immigration team.

GRANULES PHARMACEUTICALS sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 132 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles GRANULES PHARMACEUTICALS most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at GRANULES PHARMACEUTICALS:

The most frequently sponsored role is Biochemist with 20 filings at a median salary of $67,038. This is followed by Biochemist I (10 filings) and Pharmaceutical Manufacturing Quality Control Analyst.

GRANULES PHARMACEUTICALS's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where GRANULES PHARMACEUTICALS sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top GRANULES PHARMACEUTICALS H-1B locations:

The largest H-1B hub for GRANULES PHARMACEUTICALS is Chantilly, VA with 131 filings at a median salary of $78,000. The highest-paying location is Manassas, VA at $120,000 median. Salaries range from $78,000 to $120,000 across office locations.

GRANULES PHARMACEUTICALS's median H-1B salary has increased by +32% from FY 2020 ($63,419) to FY 2026 ($83,928). Tracking salary trends over time reveals how GRANULES PHARMACEUTICALS adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at GRANULES PHARMACEUTICALS.

Year-by-year breakdown:

• FY 2022: $76,461 (24 certified)
• FY 2023: $115,000 (22 certified)
• FY 2024: $121,000 (7 certified)
• FY 2025: $75,000 (47 certified)
• FY 2026: $83,928 (3 certified)

This 32% growth reflects strong compensation adjustments at GRANULES PHARMACEUTICALS, keeping pace with market demands for H-1B talent.

GRANULES PHARMACEUTICALS primarily files H-1B applications at Wage Level I, accounting for 51% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making GRANULES PHARMACEUTICALS's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

A significant portion of GRANULES PHARMACEUTICALS's H-1B filings are at entry-level (Level I) wages. These positions may face more competition in the H-1B lottery.

GRANULES PHARMACEUTICALS's median H-1B salary of $78,000 is 35% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating GRANULES PHARMACEUTICALS's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare GRANULES PHARMACEUTICALS's offerings with similar companies in your field for a more accurate assessment.

GRANULES PHARMACEUTICALS's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. GRANULES PHARMACEUTICALS files 51% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 132 certified filings, GRANULES PHARMACEUTICALS invests significantly in H-1B sponsorship. The company's 2.2% denial rate suggests solid H-1B processing practices.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.